Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.34 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | APLNR | P35414 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19261611 | 0.91 | CYP1A2 (0.35) | CYP1A2TSHRL3MBTL1CYP3A4HPGD | |
| SCHEMBL19996919 | 0.86 | CXCR5 (0.30) | CXCR5 | |
| SCHEMBL20858549 | 0.85 | CYP1A2 (0.38) | CYP1A2TSHRL3MBTL1CYP3A4HPGD | |
| SCHEMBL29768240 | 0.84 | CYP1A2 (0.33) | CYP1A2TSHRL3MBTL1CYP3A4HPGD | |
| SCHEMBL22940624 | 0.79 | CYP1A2 (0.35) | CYP1A2TSHRCYP3A4MAPK1HSD17B10 | |
| SCHEMBL18746416 | 0.79 | PADI4 (0.39) | CYP1A2TSHRCYP3A4HPGDMAPK1 | |
| SCHEMBL22180690 | 0.79 | — | — | |
| SCHEMBL24609459 | 0.79 | KDM4E (0.30) | CYP1A2 | |
| SCHEMBL21363360 | 0.79 | MAOA (0.33) | ESR1ESR2 | |
| SCHEMBL24917385 | 0.78 | CYP1A2 (0.44) | CYP1A2TSHRL3MBTL1CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814395-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| US-11691957-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814395-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, MCM4 | CYP1A2 2378/4885TSHR 4661/4885L3MBTL1 1626/4885 |
| US-11691957-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CCNT1, CCNA1 | CYP1A2 824/4885TSHR 3200/4885L3MBTL1 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.